Company page
Helix Biopharma Corp.
Helix Biopharma Corp. is a public company traded under the ticker HBPCF in the American market. The company has a market capitalization of approximately $76.7 million. Helix Biopharma focuses on developing innovative therapies for the treatment of cancer.
- Ticker
- HBP:TSX
- Asset type
- Stock
- Market cap
- $76.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSX
- Currency
- CAD